Ghiadoni Lorenzo, Bruno Rosa Maria, Stea Francesco, Virdis Agostino, Taddei Stefano
Department of Internal Medicine, University of Pisa, Via Roma, 67, 56100 Pisa, Italy.
Curr Hypertens Rep. 2009 Jun;11(3):190-6. doi: 10.1007/s11906-009-0034-5.
Central blood pressure is dependent on the stiffness of large arteries and pulse wave reflection. These parameters are very important in the development of hypertensive target organ disease. Moreover, recent clinical studies have shown their independent predictive value for cardiovascular morbidity and mortality. Therefore, 2007 guidelines for the management of hypertension inserted the evaluation of central arterial stiffness as an important component for assessing total cardiovascular risk. Differences in the way various antihypertensive drugs affect arterial stiffness and central hemodynamics may explain the greater cardio-vascular protection provided by newer drugs (eg, renin-angiotensin system blockers or calcium channel blockers) independent of peripheral blood pressure reduction, as shown by recent clinical studies. However, the predictive value of the attenuation of arterial stiffness, wave reflections, and central blood pressure still needs to be confirmed in prospective, long-term, large-scale therapeutic trials. Thus, whether these measurements should be routinely performed as a diagnostic or therapeutic indicator remains debatable.
中心血压取决于大动脉的僵硬度和脉搏波反射。这些参数在高血压靶器官疾病的发展中非常重要。此外,最近的临床研究表明它们对心血管发病率和死亡率具有独立的预测价值。因此,2007年高血压管理指南将中心动脉僵硬度评估作为评估总体心血管风险的重要组成部分。各种抗高血压药物影响动脉僵硬度和中心血流动力学的方式存在差异,这可能解释了较新药物(如肾素-血管紧张素系统阻滞剂或钙通道阻滞剂)能提供更大的心血管保护作用,且独立于外周血压降低,正如最近的临床研究所显示的那样。然而,动脉僵硬度、波反射和中心血压衰减的预测价值仍需要在前瞻性、长期、大规模治疗试验中得到证实。因此,这些测量是否应作为诊断或治疗指标常规进行仍存在争议。